Current report No. 23/2022 – Registration of changes to the Company’s Articles of Association
19 September 2022 | Current reports
Current report No. 23/2022 Date prepared: 09/14/2022 Abbreviated name of the issuer: CELON PHARMA S.A. Topic: Registration of changes to the Company’s Articles of Association Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering – current and periodical information Content of the report: The Management Board of Celon Pharma S.A.Read more »
Welcome to Celon Pharma S.A.
Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life.
News
- Current report No. 23/2022 – Registration of changes to the Company’s Articles of AssociationCurrent report No. 23/2022 Date prepared: 09/14/2022 Abbreviated name of the issuer: CELON PHARMA S.A. Topic: Registration of changes to the Company’s Articles of Association Legal basis: Article 56 subs.Read more »
- Current report No. 22/2022 – Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company’s share in the stock exchange tradingCurrent report No. 22/2022Date prepared: 18/07/2022Abbreviated name of the issuer: CELON PHARMA S.A.Subject: Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions withRead more »
- Current report 21/2022 – Admission and introduction of 5,000 ordinary C-series bearer shares of the Company to stock exchange tradingCurrent report No. 21/2022 Date prepared: 15/07/2022 Abbreviated name of the issuer: CELON PHARMA S.A. Subject: Admission and introduction of 5,000 ordinary C-series bearer shares of the Company to stockRead more »
Research and development
We create innovative drugs, that will change the lives of patients globally
Products
We are leaders in
inhalation technology
